Guaifenesin Oral Suspension (Anhydrous)
Guaifenesin is a compounded formulation containing Guaifenesin, prepared by Mixlab for veterinary use. Available by prescription.
How to Give Anhydrous Oral Suspension
Oral Suspension (Anhydrous) is a liquid medication that does not contain water in its base. This might be an oil-based or other special base to help stabilize the medicine. It will look like a regular liquid medication, but often needs a good shake because the drug can settle. Here's how to give it:
- Shake well each time to mix the medication (5-10 seconds).
- Measure the dose using the syringe/dropper provided or one recommended by your vet. Insert the top of the oral syringe into the bottle adapter. Turn the bottle upside down and pull the plunger until the medicine reaches the volume required
- Hold your pet steady: a towel or helper can assist with squirmy pets.
- Administer the dose slowly into the side of the mouth. Allow small pauses if needed for swallowing.
- Raise the head slightly to help the medication go down and clean any spills with a little water or tissue.
- Praise your pet and offer a treat or water (unless advised against feeding right after).
- Clean the syringe with water immediately after use. Store the bottle as directed, out of sunlight.
- Consistency is key: Shake each time, measure accurately, and contact your vet if any issues arise.
The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.
Veterinarians most commonly consider guaifenesin as a component of intravenous anesthetic induction and maintenance, particularly in equine patients undergoing short surgical procedures. In this context, it is frequently used in combination with other anesthetic agents to manage muscle tone and facilitate smooth transitions during the induction of recumbency. Beyond its role in the operating suite, guaifenesin is also selected as an expectorant for horses and other animals presented with respiratory conditions involving thick or excessive mucus.
At a pharmacological level, guaifenesin acts as a muscle relaxant by blocking nerve impulse transmission at the internuncial neurons of the spinal cord, brainstem and subcortical areas of the brain. Unlike peripheral neuromuscular blockers, it does not paralyze the respiratory muscles at therapeutic concentrations, which is a critical distinction your veterinarian evaluates when designing a protocol. As an expectorant, its mechanism involves stimulating receptors in the gastric mucosa that initiate a reflex secretion of fluid in the respiratory tract. This physiological shift results in a decrease in the viscosity of bronchial secretions, which may be part of a management approach for airway clearance. Your veterinarian will determine whether guaifenesin is appropriate based on the species, weight and the specific clinical context of the prescriptions required.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.
Commonly observed effects of guaifenesin administration, particularly when used intravenously for muscle relaxation, include a mild decrease in blood pressure and a transient increase in heart rate. If concentrations exceed therapeutic levels, clinical observations may include muscle tremors or extensor rigidity. When used as an oral expectorant, some animals may experience mild gastrointestinal shifts or decreased appetite. Owners should watch for signs of localized irritation at injection sites and report any unusual behavioral changes to their veterinarian.
This medication is typically used with extra caution or avoided in patients with known severe renal impairment or significant anemia. In horses, veterinarians monitor the concentration and rate of administration closely, as high-concentration solutions have been associated with hemolysis (the breakdown of red blood cells). Guaifenesin is also carefully evaluated for potential interactions with other central nervous system depressants, as it can influence the onset and duration of sedative effects. If you observe persistent lethargy, physical distress or unexpected changes in gastrointestinal health, contact your veterinarian promptly. Your veterinarian is the right person to provide guidance on the appropriate monitoring and support needed to ensure the medications are used safely for your pet.
Yes. While guaifenesin is available in some over-the-counter human products, veterinary-strength formulations and concentrated intravenous solutions are prescription medications that require authorization from a licensed veterinarian. Mixlab verifies all prescriptions before dispensing.
Yes. Mixlab can compound guaifenesin into specialized strengths or alternative oral formats if your veterinarian determines that a customized preparation better suits your pet's individual needs. The decision between a commercial and compounded product rests with your prescribing veterinarian.
Veterinarians commonly include guaifenesin in equine anesthetic protocols because of its ability to relax skeletal muscles without significantly affecting the muscles used for breathing. This helps facilitate a safer and smoother transition for the horse when they are being moved into a surgical position.
In an anesthetic setting, your veterinarian monitors for signs like muscle tremors or rigidity which may indicate the concentration is higher than needed. For pets receiving oral guaifenesin for respiratory issues, owners should watch for digestive upset or significant changes in energy level.
